The National Multiple Sclerosis Society and Critical Path Institute Create the Multiple Sclerosis Outcome Assessments Consortium
January 12, 2012 Recommendations For Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research In Adult Oncology
C-Path Cosponsors Workshop on Combination Drug Development for Alzheimer’s Disease Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches we
How do Patients Describe Their Depression? – Incorporating the Patient’s Voice into Instrument Development
Identifying Disease-Defining Concepts Using Spontaneous and Probed Responses from Semi-Structured Qualitative Interviews in Patients with Major Depressive Disorder
Expanding the Measurement of Treatment Benefit in Rheumatoid Arthritis (RA): The Role of the Patient-Reported Outcome Consortium’s RA Working Group
Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Accelerations Network Dr Carolyn Compton served as planning committee co-chair for the recent Institute of Medicine workshop, “Accelerating the De
